Chronic Myeloproliferative Disorders Terminated Phase Trials for Fentanyl (DB00813)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00899951Studying Fentanyl in Patients With Cancer